Northern Trust’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $513K | Buy |
|
|||||
|
2025
Q2 | $255K | Sell |
|
|||||
|
2025
Q1 | $208K | Sell |
|
|||||
|
2024
Q4 | $315K | Buy |
|
|||||
|
2024
Q3 | $644K | Buy |
|
|||||
|
2024
Q2 | $287K | Buy |
|
|||||
|
2024
Q1 | $242K | Buy |
|
|||||
|
2023
Q4 | $168K | Sell |
|
|||||
|
2023
Q3 | $196K | Hold |
|
|||||
|
2023
Q2 | $147K | Buy |
|
|||||
|
2023
Q1 | $199K | Buy |
|
|||||
|
2022
Q4 | $95.9K | Sell |
|
|||||
|
2022
Q3 | $139K | Sell |
|
|||||
|
2022
Q2 | $118K | Sell |
|
|||||
|
2022
Q1 | $150K | Sell |
|
|||||
|
2021
Q4 | $194K | Buy |
|
|||||
|
2021
Q3 | $345K | Sell |
|
|||||
|
2021
Q2 | $309K | Sell |
|
|||||
|
2021
Q1 | $913K | Sell |
|
|||||
|
2020
Q4 | $1.01M | Sell |
|
|||||
|
2020
Q3 | $1.25M | Sell |
|
|||||
|
2020
Q2 | $1.51M | Sell |
|
|||||
|
2020
Q1 | $1.01M | Buy |
|
|||||
|
2019
Q4 | $1.4M | Buy |
|
|||||
|
2019
Q3 | $1.8M | Buy |
|
|||||
|
2019
Q2 | $556K | Buy |
|
|||||
|
2019
Q1 | $458K | Buy |
|
|||||
|
2018
Q4 | $298K | Sell |
|
|||||
|
2018
Q3 | $529K | Buy |
|
|||||
|
2018
Q2 | $551K | Buy |
|
|||||
|
2018
Q1 | $376K | Sell |
|
|||||
|
2017
Q4 | $279K | Buy |
|
|||||
|
2017
Q3 | $173K | Buy |
|
|||||
|
2017
Q2 | $185K | Buy |
|
|||||
|
2017
Q1 | $165K | Buy |
|
|||||
|
2016
Q4 | $44K | Buy |
|
|||||
|
2016
Q3 | $49K | Hold |
|
|||||
|
2016
Q2 | $63K | Buy |
|
|||||
|
2016
Q1 | $56K | Sell |
|
|||||
|
2015
Q4 | $71K | Sell |
|
|||||
|
2015
Q3 | $151K | Sell |
|
|||||
|
2015
Q2 | $498K | Sell |
|
|||||
|
2015
Q1 | $684K | Buy |
|
|||||
|
2014
Q4 | $707K | Sell |
|
|||||
|
2014
Q3 | $1.04M | Buy |
|
|||||
|
2014
Q2 | $885K | Buy |
|
|||||
|
2014
Q1 | $616K | Buy |
|
|||||
|
2013
Q4 | $286K | Buy |
|
|||||
|
2013
Q3 | $320K | Buy |
|